Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,018 | 4,364 | 5,037 | 6,566 | 8,403 |
| Receivables | 38 | N/A | N/A | N/A | 37 |
| Other current assets | 14 | 117 | 171 | 168 | 0 |
| TOTAL | $10,113 | $4,673 | $5,444 | $7,028 | $8,492 |
| Non-Current Assets | |||||
| PPE Net | 7 | 1 | 1 | 2 | 2 |
| Other Non-Current Assets | 4 | 6 | 13 | 19 | 25 |
| TOTAL | $11 | $7 | $14 | $20 | $27 |
| Total Assets | $10,124 | $4,679 | $5,457 | $7,048 | $8,519 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,503 | 497 | 760 | 400 | 167 |
| Accrued Expenses | 1,182 | 768 | 697 | 441 | 638 |
| TOTAL | $2,684 | $1,267 | $1,465 | $856 | $827 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,684 | $1,267 | $1,465 | $856 | $827 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,880 | 1,659 | 1,068 | 1,068 | 1,068 |
| Common Shares | 2 | 1 | 16 | 16 | 1 |
| Retained earnings | -25,723 | -21,536 | -19,128 | -16,735 | -15,071 |
| TOTAL | $7,440 | $3,412 | $3,992 | $6,192 | $7,692 |
| Total Liabilities And Equity | $10,124 | $4,679 | $5,457 | $7,048 | $8,519 |